Recent News


Indu Rupassara of EnterpriseWorks startup FruitVaccine sits down with the News-Gazette to talk about the company's plant-based vaccine for hRSV. FruitVaccine is developing an orally-administered, fruit-based vaccine against hRSV, which can be eaten, as well as oral-drop vaccines for infants. The startup reeived the I-Start Award, as well as an award through the Small Business Development Center for the city of Champaign. Indu's advice for those starting out?

CATEGORY: Enterpriseworks
EarthSense Edwin Moore Family Agriculture Innovation Prize

EarthSense Recieves 2018 Edwin Moore Family Agriculture Innovation Prize Prize honors University of Illinois entrepreneurs pioneering new agricultural technologies Champaign, IL — EarthSense, a company that deve


Experts at the intersection of agriculture and technology will meet on Wednesday, Feb. 28 during the third annual Agriculture Technology Innovation Summit hosted by the University of Illinois Research Park. 

Nina Kshetry

Watch Nina Kshetry talk about her company at the News Gazette. This week's difference maker in the world of technology in Champaign-Urbana has ties to the Research Park. Nina Kshetry is the founder and president of Ensaras, Inc., which is a part of the AWARE program. 

Research Park Arial View

Read this full story at the News-Gazette.

If counted as a company, the Research Park is now the third largest employer in the county, falling just behind Carle Hospital and the University of Illinois, The News-Gazette reported in its Sunday edition. 

Employment at the park is up 17 percent since 2016, with more than 2,000 employees at the numerous companies the park is home to. 


Read the full interview at the News-Gazette.

This week, the News Gazette featured Wei Kang of PhotoniCare.  Kang is the director of research development at PhotoniCare and makes medical devices for getting images of the inner ear.

CATEGORY: Enterpriseworks

Read the full story from BloombergPursuits. 

CATEGORY: Enterpriseworks

EnterpriseWorks startup FruitVaccine is changing the world of vaccinations with an edible, orally-administered fruit-based vaccine for human respiratory syncytial virus (RSV). Founded by University of Illinois professors Dr. Indu Rupassara and Dr. Dennis Buetow in 2017, the two have worked to modify tomatoes to develop a sub-unit vaccine.

monsanto grand opening

Read about the Monsanto Grand Opening In the Press:


Illinois Homepage


EnterpriseWorks startup, Aptimmune Biologics, was recently recognized as one of seven Ag Tech start-ups to watch in 2018 by 

Aptimmune focuses on developing revolutionary swine vaccines and the prevention of the diseases, porcine reprodutive, respiratory syndrome virus ({PRRSV), and influenza. 

In November, Aptimmune launched the industry's first inactivated mucosal influenza A virus vaccine in swine. 

Recently, the company raised $6 Million Series B Funding from various investors and has moved its headquarters to St. Louis.